Sprott Inc’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-9,000
Closed -$796K 182
2016
Q4
$796K Buy
+9,000
New +$819K 0.07% 127
2016
Q2
Sell
-24,000
Closed -$2.09M 175
2016
Q1
$2.09M Buy
+24,000
New +$2.15M 0.16% 92
2015
Q2
Sell
-1,800
Closed -$206K 159
2015
Q1
$206K Buy
+1,800
New +$199K 0.02% 146

Other funds holding IBB

Sprott Inc's IBB Position: Q1 2017 in Review

Sprott Inc sold out of iShares Biotechnology ETF (IBB) in Q1 2017, closing a stake of 9,000 shares — an estimated $796K sold.

Sprott Inc first reported a position in IBB in Q1 2015 and held it in 3 quarters. The position peaked at $2.09M in Q1 2016. 520 funds tracked by Wall St. Rank hold IBB as of Q1 2017.

  • Sprott Inc reported no remaining iShares Biotechnology ETF position as of Q1 2017 after selling out during the quarter.
  • Sprott Inc sold 9,000 iShares Biotechnology ETF shares in Q1 2017, an estimated $796K.
  • Sprott Inc first reported a position in iShares Biotechnology ETF in Q1 2015 and held it in 3 quarters.
  • Sprott Inc's iShares Biotechnology ETF position peaked at $2.09M in Q1 2016.
  • 520 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2017.

Based on Sprott Inc's 13F filing for Q1 2017, filed 8 May 2017.